Home » Newsletters » BioWorld Science

BioWorld Science

April 2, 2009

View Archived Issues

Ginseng extract CVT-E002 shows promise in mouse model of asthma

Dexmedetomidine shows favorable pharmacokinetics for long-term sedation in renal failure patients

Recent Roche patent describes new benzimidazole derivatives for lipoprotein disorders

Botulinum toxin effective without anticholinergics in neurogenic detrusor hyperactivity

Novel histone deacetylase inhibitors presented by Karus Therapeutics

AstraZeneca discloses new series of Janus kinase inhibitors for cancer treatment

Dopamine D3 receptor antagonists may have potential for treating premature ejaculation

Ligand and GlaxoSmithKline collaboration identifies new lead compound

Merck KGaA and Yissum sign agreement to develop semiconductor nanoparticles

Roche claims pyridoneamide derivatives as focal adhesion kinase inhibitors

Halozyme commences PEGPH-20 dosing in patients with refractory solid tumors

Wyeth submits BLA to FDA for its 13-valent pneumococcal vaccine

FDA Advisory Committee recommends accelerated approval for Avastin

GSK's Synflorix pneumococcal vaccine receives European authorization

PF-04217903 pharmacokinetics investigated in phase I study

Phase I data on AVE-8062 in advanced solid tumor patients presented

Tadalafil lowers the ApoB/ApoA-1 ratio in healthy men

Pharming to submit MAA to EMEA for Rhucin in HAE in September 2009

GSK submits final data to FDA from phase III HPV-008 clinical study of Cervarix

QuatRx completes enrollment in second phase III clinical trial of Ophena for vaginal atrophy

NeuroSearch presents update on clinical development programs

Celtic reports positive results from phase II trial of TDT-067 for onychomycosis

GSK submits lapatinib for first-line breast cancer treatment in U.S. and E.U.

DiaMedica reports top-line results from phase IIa DM-99 study in type 2 diabetes

Once-weekly exenatide offers superior glucose control to sitagliptin or pioglitazone

KAI initiates second phase II trial for KAI-1678 in neuropathic pain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...